1. Home
  2. ENVB vs VS Comparison

ENVB vs VS Comparison

Compare ENVB & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • VS
  • Stock Information
  • Founded
  • ENVB 1994
  • VS 2013
  • Country
  • ENVB United States
  • VS Canada
  • Employees
  • ENVB N/A
  • VS N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • VS EDP Services
  • Sector
  • ENVB Health Care
  • VS Technology
  • Exchange
  • ENVB Nasdaq
  • VS Nasdaq
  • Market Cap
  • ENVB 4.2M
  • VS 4.9M
  • IPO Year
  • ENVB N/A
  • VS N/A
  • Fundamental
  • Price
  • ENVB $0.33
  • VS $1.96
  • Analyst Decision
  • ENVB Strong Buy
  • VS Hold
  • Analyst Count
  • ENVB 1
  • VS 1
  • Target Price
  • ENVB $10.00
  • VS $2.00
  • AVG Volume (30 Days)
  • ENVB 156.7K
  • VS 128.2K
  • Earning Date
  • ENVB 11-14-2024
  • VS 11-14-2024
  • Dividend Yield
  • ENVB N/A
  • VS N/A
  • EPS Growth
  • ENVB N/A
  • VS N/A
  • EPS
  • ENVB N/A
  • VS N/A
  • Revenue
  • ENVB N/A
  • VS $91,504.00
  • Revenue This Year
  • ENVB N/A
  • VS N/A
  • Revenue Next Year
  • ENVB N/A
  • VS $2,099.57
  • P/E Ratio
  • ENVB N/A
  • VS N/A
  • Revenue Growth
  • ENVB N/A
  • VS N/A
  • 52 Week Low
  • ENVB $0.30
  • VS $1.00
  • 52 Week High
  • ENVB $2.92
  • VS $9.59
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 40.19
  • VS 55.29
  • Support Level
  • ENVB $0.34
  • VS $1.69
  • Resistance Level
  • ENVB $0.37
  • VS $1.94
  • Average True Range (ATR)
  • ENVB 0.03
  • VS 0.24
  • MACD
  • ENVB 0.01
  • VS 0.03
  • Stochastic Oscillator
  • ENVB 53.66
  • VS 48.99

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

Share on Social Networks: